Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inclusion body myositis]

G Serratrice1

  • 1Service de Neurologie et des Maladies neuromusculaires, CHU La Timone, Marseille.

Presse Medicale (Paris, France : 1983)
|June 15, 1996
PubMed
Summary
This summary is machine-generated.

Inclusion body myositis (IBM) presents in three forms and is distinct from other neuromuscular diseases. Research is ongoing into its abnormal protein deposits and potential genetic links.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous muscle activity, Morvan's syndrome and limbic encephalitis: ionic or non ionic disorders?

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2011
Same author

Clinical semiology of neuromuscular diseases (5).

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2009
Same author

Clinical semiology of neuromuscular diseases (3).

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2008
Same author

[Primary muscle cramps].

Revue neurologique·2008
Same author

Detection of genetically modified organisms in food: comparison among three different DNA extraction methods.

Veterinary research communications·2007
Same author

Clinical semiology of neuromuscular diseases. Bent spine myopathy or syndrome.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2007
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Neurology
  • Pathology
  • Genetics

Context:

  • Inclusion body myositis (IBM) is a recently recognized neuromuscular disorder with an uncertain definition.
  • IBM was initially misclassified as inflammatory dermatomyositis but presents distinct clinical and pathological features.

Purpose:

  • To clarify the definition and characteristics of inclusion body myositis.
  • To differentiate IBM from other neuromuscular conditions.
  • To explore the underlying pathology, including abnormal protein deposits and genetic factors.

Summary:

  • Inclusion body myositis (IBM) exhibits three distinct clinical forms: disseminated muscle atrophy/weakness, pseudopolymyositis, and pseudo-degenerative disease.
  • Pathologically, IBM is characterized by abnormal deposits within muscle fibers, potentially containing amyloid, beta-amyloid precursor, ubiquitin, tau protein, and prions, though their significance is unknown.

Related Experiment Videos

  • Mitochondrial DNA deletions are observed but not considered causal, while hereditary forms linked to chromosome 9 abnormalities are increasingly recognized.

    • Impact:

    • Improved diagnostic criteria for inclusion body myositis.
    • Enhanced understanding of the molecular pathology of IBM.
    • Potential identification of genetic targets for future therapeutic strategies.